Fisher Asset Management’s AnaptysBio ANAB Stock Holding History
Bought
Maintained
Sold
Other funds holding ANAB
S
BFG
TE
Fisher Asset Management's ANAB Position: Q2 2026 in Review
Fisher Asset Management sold out of AnaptysBio (ANAB) in Q2 2026, closing a stake of 56,596 shares — an estimated $3.14M sold.
Fisher Asset Management first reported a position in ANAB in Q3 2021 and held it in 19 quarters. The position peaked at $3.14M in Q1 2026. 61 funds tracked by Wall St. Rank hold ANAB as of Q2 2026.
- Fisher Asset Management reported no remaining AnaptysBio position as of Q2 2026 after selling out during the quarter.
- Fisher Asset Management sold 56,596 AnaptysBio shares in Q2 2026, an estimated $3.14M.
- Fisher Asset Management first reported a position in AnaptysBio in Q3 2021 and held it in 19 quarters.
- Fisher Asset Management's AnaptysBio position peaked at $3.14M in Q1 2026.
- 61 funds tracked by Wall St. Rank held AnaptysBio as of Q2 2026.
Based on Fisher Asset Management's 13F filing for Q2 2026, filed 4 Aug 2026.